Severe Outcomes in Suspected Pediatric Delta-8-THC Exposures.
作者信息
Ostrowski Simon J, Scanlon Matthew P, Barton David J, Lynch Michael J, Trautman William J
机构信息
Department of Emergency Medicine, Division of Medical Toxicology, University of Pittsburgh Medical Center, 3600 Forbes Avenue, Iroquois Building, 4th floor, Suite 400, Pittsburgh, PA, 15213, USA.
Department of Emergency Medicine, University of Pittsburgh Medical Center, Pittsburgh, USA.
出版信息
J Med Toxicol. 2025 Jan;21(1):89-92. doi: 10.1007/s13181-024-01055-4. Epub 2024 Dec 24.
Abstract
摘要
相似文献
1
Severe Outcomes in Suspected Pediatric Delta-8-THC Exposures.疑似儿童接触δ-8-四氢大麻酚的严重后果。
J Med Toxicol. 2025 Jan;21(1):89-92. doi: 10.1007/s13181-024-01055-4. Epub 2024 Dec 24.
2
Sedation and Acute Encephalopathy in a Pediatric Patient Following Ingestion of Delta-8-Tetrahydrocannabinol Gummies.摄入 δ-8-四氢大麻酚软糖后小儿患者镇静和急性脑病。
Am J Case Rep. 2021 Nov 11;22:e933488. doi: 10.12659/AJCR.933488.
3
Effects of Δ-Tetrahydrocannabinol and the Aminoalkylindole K2/Spice Constituent JWH-073 on Cardiac Tissue and Mesenteric Vascular Reactivity.Δ-四氢大麻酚和氨基烷基吲哚 K2/香料成分 JWH-073 对心脏组织和肠系膜血管反应性的影响。
Cannabis Cannabinoid Res. 2024 Aug;9(4):e1056-e1062. doi: 10.1089/can.2022.0325. Epub 2023 Apr 3.
4
Unintentional ingestion of putative delta-8 tetrahydrocannabinol by two youth requiring critical care: a case report.两名青少年意外摄入疑似δ-8四氢大麻酚并需要重症监护：一例报告
J Cannabis Res. 2023 Mar 21;5(1):9. doi: 10.1186/s42238-023-00176-x.
5
The Pharmacokinetics and Pharmacodynamics of a Hemp-Derived "Full-Spectrum" Oral Cannabinoid Product with a 1:1 Ratio of Cannabidiol to Cannabidiolic Acid and Delta-9-Tetrahydrocannabinol to Delta-9-Tetrahydrocannabinolic Acid: A Double-Blind, Placebo-Controlled, Within-Subjects Human Laboratory Study.一种大麻衍生的“全谱”口服大麻素产品的药代动力学和药效学，该产品中大麻二酚与大麻二酚酸以及Δ9-四氢大麻酚与Δ9-四氢大麻酚酸的比例为1:1：一项双盲、安慰剂对照、受试者内人体实验室研究。
Cannabis Cannabinoid Res. 2025 Apr;10(2):e299-e313. doi: 10.1089/can.2024.0187. Epub 2025 Mar 5.
6
Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.在恒河猴辨别Δ9-四氢大麻酚的实验中对大麻素激动剂的表征及大麻素拮抗剂的表观pA2分析
J Pharmacol Exp Ther. 2006 Dec;319(3):1211-8. doi: 10.1124/jpet.106.107110. Epub 2006 Aug 30.
7
Effect of chronic administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice.慢性给予R-(+)-[2,3-二氢-5-甲基-3-[(吗啉基)甲基]吡咯并[1,2,3-de]-1,4-苯并恶嗪基]-(1-萘基)甲磺酸盐（WIN55,212-2）或δ(9)-四氢大麻酚对小鼠大麻素受体适应性的影响。
J Pharmacol Exp Ther. 2002 Oct;303(1):36-44. doi: 10.1124/jpet.102.035618.
8
Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol.成年雄性大鼠长期暴露于Δ⁹-四氢大麻酚后，其基底神经节和小脑中的大麻素受体、WIN-55,212-2刺激的[³⁵S]GTPγS结合以及大麻素受体mRNA水平
J Mol Neurosci. 1998 Oct;11(2):109-19. doi: 10.1385/JMN:11:2:109.
9
Oxidative stress and cannabinoid receptor expression in type-2 diabetic rat pancreas following treatment with Δ⁹-THC.Δ⁹-四氢大麻酚治疗后2型糖尿病大鼠胰腺中的氧化应激与大麻素受体表达
Cell Biochem Funct. 2014 Oct;32(7):612-9. doi: 10.1002/cbf.3058. Epub 2014 Sep 3.
10
The cross-reactivity of cannabinoid analogs (delta-8-THC, delta-10-THC and CBD), their metabolites and chiral carboxy HHC metabolites in urine of six commercially available homogeneous immunoassays.六种市售均相免疫分析试剂尿液中大麻素类似物（Δ-8-THC、Δ-10-THC 和 CBD）、其代谢物和手性羧酸 HHCM 代谢物的交叉反应性。
J Anal Toxicol. 2023 Nov 1;47(8):732-736. doi: 10.1093/jat/bkad059.
本文引用的文献
1
Delta-8 tetrahydrocannabinol, delta-10 tetrahydrocannabinol, and tetrahydrocannabinol-O acetate exposures reported to America's Poison Centers.向美国毒物控制中心报告的δ-8四氢大麻酚、δ-10四氢大麻酚和四氢大麻酚-O乙酸酯暴露情况。
Clin Toxicol (Phila). 2024 Apr;62(4):256-266. doi: 10.1080/15563650.2024.2340115. Epub 2024 Apr 30.
2
Adolescent Δ8-THC and Marijuana Use in the US.美国青少年使用Δ8-四氢大麻酚和大麻的情况。
JAMA. 2024 Mar 12;331(10):861-865. doi: 10.1001/jama.2024.0865.
3
Commercial Delta-8 THC Products: an Analysis of Content and Labeling.商业 Delta-8 THC 产品：含量与标签分析。
J Med Toxicol. 2024 Jan;20(1):31-38. doi: 10.1007/s13181-023-00974-y. Epub 2023 Nov 2.
4
Toxic Tetrahydrocannabinol (THC) Dose in Pediatric Cannabis Edible Ingestions.小儿大麻食用制品中有毒四氢大麻酚（THC）剂量。
Pediatrics. 2023 Sep 1;152(3). doi: 10.1542/peds.2023-061374.
5
Severe outcomes following pediatric cannabis intoxication: a prospective cohort study of an international toxicology surveillance registry.儿童大麻中毒后的严重后果：一项国际毒理学监测登记处的前瞻性队列研究。
Clin Toxicol (Phila). 2023 Aug;61(8):591-598. doi: 10.1080/15563650.2023.2238121. Epub 2023 Aug 21.
6
The cross-reactivity of cannabinoid analogs (delta-8-THC, delta-10-THC and CBD), their metabolites and chiral carboxy HHC metabolites in urine of six commercially available homogeneous immunoassays.六种市售均相免疫分析试剂尿液中大麻素类似物（Δ-8-THC、Δ-10-THC 和 CBD）、其代谢物和手性羧酸 HHCM 代谢物的交叉反应性。
J Anal Toxicol. 2023 Nov 1;47(8):732-736. doi: 10.1093/jat/bkad059.
7
Delta-8-Tetrahydrocannabinol Exposure and Confirmation in Four Pediatric Patients.Delta-8-四氢大麻酚暴露及 4 例儿科患者的确认。
J Med Toxicol. 2023 Apr;19(2):190-195. doi: 10.1007/s13181-022-00927-x. Epub 2023 Feb 9.
8
Determination of Cross-Reactivity of Contemporary Cannabinoids with THC Direct Immunoassay (ELISA) in Whole Blood.当代大麻素与全血中 THC 直接免疫测定（ELISA）交叉反应性的测定。
J Anal Toxicol. 2022 Oct 14;46(8):844-851. doi: 10.1093/jat/bkac051.
9
Review of delta-8-tetrahydrocannabinol (Δ -THC): Comparative pharmacology with Δ -THC.δ-8-四氢大麻酚（Δ -THC）的综述：与 Δ -THC 的比较药理学。
Br J Pharmacol. 2022 Aug;179(15):3915-3933. doi: 10.1111/bph.15865. Epub 2022 Jun 1.
10
Sedation and Acute Encephalopathy in a Pediatric Patient Following Ingestion of Delta-8-Tetrahydrocannabinol Gummies.摄入 δ-8-四氢大麻酚软糖后小儿患者镇静和急性脑病。
Am J Case Rep. 2021 Nov 11;22:e933488. doi: 10.12659/AJCR.933488.
Zotero 插件